Privia Health Group, Inc. (PRVA) shareholders
PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3060% above fair value
$24.55+0.88 (+3.72%)
Close on Nov 13, 2026Market cap $3.14BP/E 94.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
96.7%
124M of 128M shares
Institutional holders
301
46 new, 34 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 40 sales
Net sold $22.24M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 17,929,937 | 14.20% | 13G (passive) amendment | Jun 30, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (10.10%) | 12,364,531 | 10.10% | 13G (passive) amendment | Sep 30, 2025 |
| Durable Capital Partners LP | 11,109,588 | 9.30% | 13G (passive) amendment | Sep 30, 2024 |
| Vanguard Capital Management | 6,513,393 | 5.09% | 13G (passive) | Sep 30, 2026 |
| Rubicon Founders OP GP, LP Joint filing with Puma Growth Holdings, LLC (5.07%), Rubicon Founders OP GP 2 LLC (5.07%) and 2 more | 6,472,513 | 5.07% | 13D (active) | Sep 1, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (5.00%) | 6,385,121 | 5.00% | 13G (passive) amendment | Sep 30, 2026 |
| Vanguard Portfolio Management | 6,382,685 | 5.16% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PRVA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 21,402,417 | 16.76% | $550.68M | +2,344,507 | 0.01% |
| FMR LLC | 12,848,437 | 10.06% | $330.59M | −197,105 | 0.01% |
| Durable Capital Partners LP | 11,635,948 | 9.11% | $299.39M | −451,895 | 2.91% |
| Vanguard Portfolio Management LLC | 6,572,384 | 5.15% | $169.11M | +290,842 | 0.01% |
| Rubicon Founders LLC | 5,971,079 | 4.67% | $153.64M | +22,415 | 78.21% |
| Vanguard Capital Management LLC | 5,156,720 | 4.04% | $132.68M | +147,897 | 0.00% |
| State Street Corp | 4,905,789 | 3.84% | $126.23M | +415,889 | 0.00% |
| Van Berkom & Associates Inc. | 3,711,623 | 2.91% | $95.50M | −4,394,463 | 3.08% |
| Geode Capital Management, LLC | 3,130,473 | 2.45% | $80.56M | +234,939 | 0.00% |
| Riverbridge Partners LLC | 2,998,597 | 2.35% | $77.15M | −919,351 | 2.15% |
| Bank of New York Mellon Corp | 2,892,536 | 2.26% | $74.42M | −50,957 | 0.01% |
| Principal Financial Group Inc | 2,587,878 | 2.03% | $66.59M | −135,195 | 0.03% |
| Dimensional Fund Advisors LP | 2,551,861 | 2.00% | $65.66M | +145,144 | 0.01% |
| Wellington Management Group Llp | 2,130,289 | 1.67% | $54.81M | +1,906,187 | 0.01% |
| UBS Asset Management Americas Inc | 1,948,021 | 1.53% | $50.12M | −103,638 | 0.01% |
| BlackBarn Capital Partners LP | 1,585,000 | 1.24% | $40.78M | – | 3.44% |
| Nuveen, LLC | 1,465,145 | 1.15% | $37.70M | +517,009 | 0.01% |
| Bank Of America Corp /De/ | 1,432,117 | 1.12% | $36.85M | +175,939 | 0.00% |
| Charles Schwab Investment Management Inc | 1,374,828 | 1.08% | $35.37M | +55,722 | 0.00% |
| Goldman Sachs Group Inc | 1,302,019 | 1.02% | $33.50M | −37,931 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 301 | 124M | 96.7% | 46 / 114 | 102 / 34 | 10M | 12M |
| Q1 2026 | 293 | 125M | 97.8% | 52 / 102 | 98 / 31 | 23M | 7M |
| Q4 2025 | 276 | 121M | 94.6% | 49 / 112 | 76 / 27 | 6M | 4M |
| Q3 2025 | 259 | 120M | 93.8% | 31 / 104 | 87 / 50 | 10M | 8M |
| Q2 2025 | 281 | 118M | 92.3% | 53 / 109 | 88 / 19 | 8M | 11M |
| Q1 2025 | 249 | 121M | 94.6% | 37 / 88 | 87 / 17 | 11M | 8M |
| Q4 2024 | 231 | 120M | 94.1% | 27 / 102 | 64 / 30 | 6M | 6M |
| Q3 2024 | 234 | 120M | 93.9% | 32 / 78 | 89 / 21 | 26M | 7M |
| Q2 2024 | 225 | 118M | 92.5% | 30 / 70 | 93 / 36 | 8M | 10M |
| Q1 2024 | 233 | 121M | 94.8% | 37 / 96 | 69 / 28 | 10M | 7M |
| Q4 2023 | 226 | 118M | 92.7% | 31 / 97 | 71 / 19 | 13M | 6M |
| Q3 2023 | 218 | 111M | 86.9% | 28 / 90 | 71 / 42 | 8M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
284 funds held PRVA in Q2 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PRVA | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7,137,000 | 5.59% | $183.64M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 3,589,974 | 2.81% | $92.37M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,146,350 | 2.46% | $80.96M | 0.10% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,599,416 | 2.04% | $66.88M | 0.04% | Jun 30, 2026 |
| Select Health Care Portfolio | 2,500,000 | 1.96% | $53.78M | 0.93% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1,501,521 | 1.18% | $38.63M | 0.08% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,359,812 | 1.06% | $34.99M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,321,438 | 1.03% | $31.28M | 0.09% | Jul 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1,285,000 | 1.01% | $27.64M | 0.01% | May 31, 2026 |
| Fidelity Small Cap Growth Fund | 1,283,039 | 1.00% | $30.37M | 0.35% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 1,115,917 | 0.87% | $28.71M | 0.19% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 1,085,362 | 0.85% | $27.93M | 0.17% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 1,065,858 | 0.83% | $27.42M | 0.33% | Jun 30, 2026 |
| Franklin Small Cap Growth Fund | 1,039,286 | 0.81% | $24.60M | 1.00% | Jul 31, 2026 |
| Fidelity Advisor Health Care Fund | 896,700 | 0.70% | $21.22M | 0.68% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Parth Mehrotra | Chief Executive Officer, Director | 437,174 | 0.34% | May 13, 2026 |
| David Mountcastle | EVP & Chief Financial Officer | 173,548 | 0.14% | Jul 13, 2026 |
| Edward C. Fargis | EVP & General Counsel | 111,979 | 0.09% | Mar 12, 2026 |
| Opella Finley Ernest | Director | 6,350 | 0.00% | Sep 3, 2026 |
| Matthew Shawn Morris | Director | 154,858 | 0.12% | Jul 7, 2026 |
| Lance Berberian | Director | 16,131 | 0.01% | May 22, 2026 |
| Pamela O. Kimmet | Director | 34,172 | 0.03% | May 22, 2026 |
| Francis S. Soistman Jr | Director | 8,463 | 0.01% | May 22, 2026 |
| Nancy G. Cocozza | Director | 42,814 | 0.03% | May 22, 2026 |
| Thomas A. McCarthy | Director | 69,470 | 0.05% | May 22, 2026 |
| David P. King | Director | 50,775 | 0.04% | May 22, 2026 |
| Jaewon Ryu | Director | 47,110 | 0.04% | May 22, 2026 |
| David S. Wichmann | Director | 1,341,049 | 1.05% | May 23, 2025 |
| Patricia Anne Maryland | Director | 42,312 | 0.03% | May 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Opella Finley Ernest Director | Sep 1, 2026 | Award | +6,350 | – | – | 6,350 |
| David Mountcastle EVP & Chief Financial Officer | Jul 9, 2026 | Sale(10b5-1 plan) | −21,275 | $27.67 | $588.68K | 164,853 |
| David Mountcastle EVP & Chief Financial Officer | Jul 7, 2026 | Sale(10b5-1 plan) | −600 | $27.57 | $16.54K | 186,128 |
| Matthew Shawn Morris Director | Jul 6, 2026 | Option exercise | +53,722 | $2.00 | $107.44K | 130,373 |
| Matthew Shawn Morris Director | Jul 6, 2026 | Sale(10b5-1 plan) | −53,722 | $27.24 | $1.46M | 68,188 |
| David Mountcastle EVP & Chief Financial Officer | Jul 2, 2026 | Sale(10b5-1 plan) | −24,734 | $27.50 | $680.19K | 186,728 |
| Matthew Shawn Morris Director | Jul 2, 2026 | Sale(10b5-1 plan) | −59,037 | $27.33 | $1.61M | 76,651 |
| Matthew Shawn Morris Director | Jul 2, 2026 | Option exercise | +59,037 | $2.00 | $118.07K | 135,688 |
| Matthew Shawn Morris Director | Jul 1, 2026 | Option exercise | +82,675 | $2.00 | $165.35K | 159,326 |
| Matthew Shawn Morris Director | Jul 1, 2026 | Sale(10b5-1 plan) | −45,634 | $26.52 | $1.21M | 113,692 |
| Matthew Shawn Morris Director | Jul 1, 2026 | Sale(10b5-1 plan) | −37,041 | $26.93 | $997.51K | 76,651 |
| Matthew Shawn Morris Director | Jun 30, 2026 | Option exercise | +52,823 | $2.00 | $105.65K | 129,474 |
| Matthew Shawn Morris Director | Jun 30, 2026 | Sale(10b5-1 plan) | −52,823 | $25.72 | $1.36M | 76,651 |
| Matthew Shawn Morris Director | Jun 29, 2026 | Option exercise | +63,212 | $2.00 | $126.42K | 139,863 |
| Matthew Shawn Morris Director | Jun 29, 2026 | Sale(10b5-1 plan) | −63,212 | $25.33 | $1.60M | 76,651 |
| David Mountcastle EVP & Chief Financial Officer | Jun 26, 2026 | Option exercise | +17,196 | $2.00 | $34.39K | 228,658 |
| David Mountcastle EVP & Chief Financial Officer | Jun 26, 2026 | Sale(10b5-1 plan) | −17,196 | $25.18 | $433.00K | 211,462 |
| Matthew Shawn Morris Director | Jun 26, 2026 | Sale(10b5-1 plan) | −88,110 | $25.33 | $2.23M | 76,651 |
| Matthew Shawn Morris Director | Jun 26, 2026 | Option exercise | +88,110 | $2.00 | $176.22K | 164,761 |
| Nancy G. Cocozza Director | May 20, 2026 | Award | +8,463 | – | – | 42,814 |
| Lance Berberian Director | May 20, 2026 | Award | +8,463 | – | – | 16,131 |
| David P. King Director | May 20, 2026 | Award | +8,463 | – | – | 50,775 |
| Thomas A. McCarthy Director | May 20, 2026 | Award | +8,463 | – | – | 27,983 |
| Jaewon Ryu Director | May 20, 2026 | Award | +8,463 | – | – | 47,110 |
| Matthew Shawn Morris Director | May 20, 2026 | Award | +8,463 | – | – | 76,651 |
| Francis S. Soistman Jr Director | May 20, 2026 | Award | +8,463 | – | – | 8,463 |
| Pamela O. Kimmet Director | May 20, 2026 | Award | +8,463 | – | – | 34,172 |
| Parth Mehrotra Chief Executive Officer, Director | May 12, 2026 | Sale(10b5-1 plan) | −15,647 | $22.64 | $354.25K | 434,357 |
| David Mountcastle EVP & Chief Financial Officer | May 11, 2026 | Sale | −3,385 | $22.60 | $76.50K | 211,462 |
| Parth Mehrotra Chief Executive Officer, Director | May 11, 2026 | Sale(10b5-1 plan) | −105,439 | $22.55 | $2.38M | 450,004 |
| Matthew Shawn Morris Director | May 4, 2026 | Sale(10b5-1 plan) | −1,017 | $24.96 | $25.38K | 68,188 |
| Matthew Shawn Morris Director | May 4, 2026 | Option exercise | +1,017 | $2.00 | $2.03K | 69,205 |
| David Mountcastle EVP & Chief Financial Officer | May 4, 2026 | Sale(10b5-1 plan) | −1,206 | $25.00 | $30.15K | 214,847 |
| David Mountcastle EVP & Chief Financial Officer | May 4, 2026 | Option exercise | +1,206 | $2.00 | $2.41K | 216,053 |
| Matthew Shawn Morris Director | May 1, 2026 | Option exercise | +17,096 | $2.00 | $34.19K | 85,284 |
| Matthew Shawn Morris Director | May 1, 2026 | Sale(10b5-1 plan) | −17,096 | $24.99 | $427.23K | 68,188 |
| David Mountcastle EVP & Chief Financial Officer | May 1, 2026 | Option exercise | +7,179 | $2.00 | $14.36K | 222,026 |
| David Mountcastle EVP & Chief Financial Officer | May 1, 2026 | Sale(10b5-1 plan) | −7,179 | $25.03 | $179.69K | 214,847 |
| David Mountcastle EVP & Chief Financial Officer | Apr 2, 2026 | Sale | −5,566 | $20.85 | $116.05K | 214,847 |
| David Mountcastle EVP & Chief Financial Officer | Mar 16, 2026 | Sale | −6,391 | $22.11 | $141.31K | 220,413 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 16, 2026 | Sale | −26,509 | $22.11 | $586.11K | 555,443 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 13, 2026 | Sale | −27,229 | $21.52 | $585.97K | 581,952 |
| David Mountcastle EVP & Chief Financial Officer | Mar 13, 2026 | Sale | −6,565 | $21.52 | $141.28K | 226,804 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 12, 2026 | Sale | −26,763 | $21.90 | $586.11K | 609,181 |
| David Mountcastle EVP & Chief Financial Officer | Mar 12, 2026 | Sale | −6,453 | $21.90 | $141.32K | 233,369 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 11, 2026 | Award | +171,904 | – | – | 635,944 |
| David Mountcastle EVP & Chief Financial Officer | Mar 11, 2026 | Award | +42,584 | – | – | 239,822 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 10, 2026 | Sale(10b5-1 plan) | −21,097 | $22.71 | $479.11K | 322,698 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 10, 2026 | Award | +141,342 | – | – | 464,040 |
| David Mountcastle EVP & Chief Financial Officer | Mar 10, 2026 | Award | +35,335 | – | – | 197,238 |
| Edward C. Fargis EVP & General Counsel | Mar 10, 2026 | Award | +28,268 | – | – | 111,979 |
| David Mountcastle EVP & Chief Financial Officer | Mar 9, 2026 | Sale | −5,829 | $22.84 | $133.13K | 161,903 |
| Edward C. Fargis EVP & General Counsel | Mar 9, 2026 | Sale | −4,949 | $22.84 | $113.04K | 83,711 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 9, 2026 | Sale(10b5-1 plan) | −1,219 | $23.37 | $28.49K | 362,660 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 9, 2026 | Sale(10b5-1 plan) | −18,865 | $22.84 | $430.88K | 343,795 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 9, 2026 | Sale(10b5-1 plan) | −21,915 | $22.84 | $500.54K | 363,879 |
| David Mountcastle EVP & Chief Financial Officer | Mar 6, 2026 | Sale | −5,177 | $23.15 | $119.85K | 167,732 |
| Edward C. Fargis EVP & General Counsel | Mar 6, 2026 | Sale | −4,394 | $23.15 | $101.72K | 88,660 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 6, 2026 | Sale(10b5-1 plan) | −21,440 | $23.15 | $496.34K | 385,794 |
| Matthew Shawn Morris Director | Feb 27, 2026 | Option exercise | +16,550 | $2.00 | $33.10K | 84,738 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
3.28%
4M shares short
Days to cover
4.5
At 1M shares a day
Change since last report
-22.2%
From 5M shares
Short volume, 20 days
39.0%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Privia Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 200 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| David Mountcastle Officer | Jul 9, 2026 | 21,275 | $588.60K | Jul 9, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Jul 7, 2026 | 600 | $16.54K | Jul 7, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Jul 2, 2026 | 24,734 | $680.19K | Jul 2, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Jun 26, 2026 | 17,196 | $433.04K | Jun 26, 2026 | Stock Option Exercise |
| Parth Mehrotra Officer, Director | May 12, 2026 | 15,647 | $354.25K | May 12, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | May 11, 2026 | 14,036 | $317.26K | May 11, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | May 11, 2026 | 3,385 | $76.51K | May 11, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | May 11, 2026 | 91,403 | $2.06M | May 11, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | May 4, 2026 | 1,206 | $30.15K | May 4, 2026 | Option Granted - 08/28/2018 |
| David Mountcastle Officer | May 1, 2026 | 7,179 | $179.68K | May 1, 2026 | Options Granted - 08/28/2018 |
| Matthew Shawn Morris Director | May 1, 2026 | 1,628,683 | $40.47M | May 1, 2026 | Acquired as compensation -- Restricted Stock Units |
| David Mountcastle Officer | Apr 2, 2026 | 5,566 | $116.06K | Apr 2, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Mar 16, 2026 | 6,391 | $141.30K | Mar 16, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | Mar 16, 2026 | 26,509 | $586.11K | Mar 16, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | Mar 13, 2026 | 27,229 | $586.12K | Mar 13, 2026 | Restricted Stock Vesting |
See a number that looks wrong?